tirzepatide effects on heart of the Clinical Trajectory of Patients With Failure, Preserved Ejection Fraction, and Obesity Can tirzepatide, a long-acting agonist

weight regain occurs after discontinuation STEP 5 (extended duration, N = 304): 104-week treatment duration (2 years) Mean weight loss: 15.2% at week 104 Weight loss plateaus between weeks 60 and 68, then remains stable with continued treatment The consistency across trials is notable

Pharmacological interventions may be considered for persistent symptoms, but only under medical supervision

Recent Research and Developments Recent studies have explored additional benefits of semaglutide beyond its use in diabetes and weight management

Study that gives important insight into the molecular mode of action of GLP-1 by identifying the cellular localization of GLP-1R in monkey and human tissue using the most extensively validated monoclonal antibody to date

Certain foods, supplements, lifestyle habits and biohacks can increase this hormone naturally, supporting blood sugar balance and weight loss without the side effects